The spinal market is the most dynamic segment of the orthopaedic device industry. Innovation is the key driving force behind this resilient growth as surgeons search for the new treatment modalities and technologies that will improve patient outcomes.

STALIF® TT is a true ‘stand alone’ anterior lumbar interbody fusion device that delivers exceptional fixation with superior clinical advantages. Unlike contemporary cage fixation devices that require supplemental pedicular screw fixation or anterior plate fixation, STALIF® TT’s unique patented design delivers solid fixation that resists flexion-extension forces, torsional rotation, and prevents graft and implant extrusion while restoring normal sagittal alignment.

This is achieved through either a single midline (trans-peritoneal) or oblique (retro-peritoneal) approach providing surgeons with the most options available for primary fusion, implant salvage, STALIF® TT/TDR hybrid and bail-out strategies. STALIF® TT is a less invasive procedure that reduces patient morbidity, blood loss, surgery time, anaesthesia, recovery time and overall expense.